Medicare Enrolled
Dr. Vladimir Royter, M.D.
Neurology · Hanford, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Royter from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Royter?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Royter
Dr. Vladimir Royter is a neurology specialist in Hanford, CA, with 16 years of NPI registration. Based on federal Medicare data, Dr. Royter performed 1,251 Medicare services across 1,038 unique beneficiaries.
Between the years covered by Open Payments, Dr. Royter received a total of $15,259 from 69 pharmaceutical and/or device companies across 838 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Royter is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 16 years in practice
▲ Top 28% volume in CA
$15,259 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,251
Medicare services
Top 28% in CA for neurology
1,038
Unique beneficiaries
$72
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~78 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
306 | $88 | $200 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
242 | $59 | $170 |
| Additional 30 minutes of psychological or neuropsychological testing This code represents an additional 30-minute increment for administering psychological or neuropsychological tests. It is used to bill for time beyond the initial testing period. |
180 | $28 | $101 |
| Psychological or neuropsychological test, first 30 minutes Administration of psychological or neuropsychological testing for the first 30 minutes. |
179 | $30 | $101 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
176 | $115 | $320 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
72 | $120 | $299 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
24 | $77 | $157 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
18 | $138 | $300 |
| Nerve conduction studies, 5-6 tests A series of 5 to 6 tests that measure how well nerves send electrical signals. The procedure evaluates nerve function and helps identify damage or dysfunction. |
14 | $91 | $250 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
14 | $48 | $160 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
14 | $84 | $250 |
| New patient office visit, complex (60-74 min) | 12 | $138 | $420 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$15,259
Total received (2018-2024)
Avg $2,180/year across 7 years
Top 19% in CA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
69
Companies
838
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,120 (99.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$139 (0.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,820
2023
$1,689
2022
$2,292
2021
$2,538
2020
$1,584
2019
$1,884
2018
$2,452
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
NEUROPACE, INC.
$735
ABBVIE INC.
$484
PFIZER INC.
$212
SK Life Science, Inc.
$132
Genentech USA, Inc.
$127
JAZZ PHARMACEUTICALS INC.
$101
ACADIA Pharmaceuticals Inc
$89
UCB, Inc.
$84
Alexion Pharmaceuticals, Inc.
$82
ANI Pharmaceuticals, Inc.
$81
Novartis Pharmaceuticals Corporation
$66
Neurocrine Biosciences, Inc.
$56
MDD US Operations, LLC
$53
Amgen Inc.
$43
Otsuka America Pharmaceutical, Inc.
$42
EMD Serono, Inc.
$40
Amneal Pharmaceuticals LLC
$38
Aucta Pharmaceuticals, Inc.
$29
Octapharma USA, Inc.
$29
Lilly USA, LLC
$28
Takeda Pharmaceuticals U.S.A., Inc.
$26
CSL Behring
$26
Eisai Inc.
$25
Monteris Medical Corporation
$24
Lundbeck LLC
$23
ARGENX US, INC.
$20
Biogen, Inc.
$20
Novo Nordisk Inc
$20
Grifols USA, LLC
$19
Kyowa Kirin, Inc.
$19
Teva Pharmaceuticals USA, Inc.
$18
Averitas Pharma Inc.
$16
MITSUBISHI TANABE PHARMA AMERICA, INC.
$16
Top 3 companies account for 50.7% of 2024 payments
All-time payments by company (2018-2024) ›
Supernus Pharmaceuticals, Inc.
$1,395
Biogen, Inc.
$1,130
LivaNova USA, Inc.
$947
UCB, Inc.
$794
ABBVIE INC.
$754
Novartis Pharmaceuticals Corporation
$737
NEUROPACE, INC.
$735
AbbVie Inc.
$665
SK Life Science, Inc.
$642
Genentech USA, Inc.
$626
Teva Pharmaceuticals USA, Inc.
$614
Alexion Pharmaceuticals, Inc.
$396
EMD Serono, Inc.
$376
PFIZER INC.
$364
Sunovion Pharmaceuticals Inc.
$320
Biohaven Pharmaceutical Holding Company Ltd.
$261
Lilly USA, LLC
$254
Horizon Therapeutics plc
$251
Allergan, Inc.
$249
Assertio Therapeutics, Inc.
$226
Amgen Inc.
$224
ACADIA Pharmaceuticals Inc
$188
Neurocrine Biosciences, Inc.
$174
Mallinckrodt LLC
$170
Adamas Pharmaceuticals, Inc.
$156
Biohaven Pharmaceuticals, Inc.
$156
ANI Pharmaceuticals, Inc.
$151
Kyowa Kirin, Inc.
$124
AstraZeneca Pharmaceuticals LP
$123
Celgene Corporation
$121
CSL Behring
$114
Eisai Inc.
$113
JAZZ PHARMACEUTICALS INC.
$101
EISAI INC.
$93
MDD US Operations, LLC
$86
ARGENX US, INC.
$74
Avanir Pharmaceuticals, Inc.
$72
Acorda Therapeutics, Inc
$70
Otsuka America Pharmaceutical, Inc.
$69
BANNER LIFE SCIENCES, LLC
$68
Upsher-Smith Laboratories LLC
$68
US WorldMeds, LLC
$68
E.R. Squibb & Sons, L.L.C.
$64
Sumitomo Pharma America, Inc.
$62
Amneal Pharmaceuticals LLC
$61
Allergan Inc.
$61
Mallinckrodt Enterprises LLC
$60
Neurelis, Inc.
$59
Lundbeck LLC
$49
Grifols USA, LLC
$49
Janssen Pharmaceuticals, Inc
$47
Banner Life Sciences, LLC
$41
MITSUBISHI TANABE PHARMA AMERICA, INC.
$39
ASSERTIO THERAPEUTICS, Inc.
$37
Aucta Pharmaceuticals, Inc.
$29
Octapharma USA, Inc.
$29
Almatica Pharma LLC
$28
Takeda Pharmaceuticals U.S.A., Inc.
$26
GENZYME CORPORATION
$25
Monteris Medical Corporation
$24
Impax Laboratories, Inc.
$24
Novo Nordisk Inc
$20
Sarepta Therapeutics, Inc.
$19
Alnylam Pharmaceuticals Inc.
$16
Averitas Pharma Inc.
$16
Boston Scientific Corporation
$16
Greenwich Biosciences, Inc.
$13
Zogenix Inc.
$13
AQUESTIVE THERAPEUTICS, INC.
$12
Top 3 companies account for 22.8% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AFINITOR · AIMOVIG · AJOVY · AMYVID · ANDEXXA · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Aimovig · Austedo XR · BAFIERTAM · BOTOX · BRILINTA · Briviact · COMIRNATY · Cambia · EMGALITY · EPIDIOLEX · Enspryng · Epidiolex · Fabhalta · Fintepla · Fycompa · GENERAL - DBS · GILENYA · GOCOVRI · Gamunex-C · Gocovri · Gralise · HYQVIA · Hizentra · INBRIJA · INGREZZA · KESIMPTA · KISUNLA · KYNMOBI · LEQEMBI · Leqembi · MAVENCLAD · MAYZENT · MYOBLOC · Mavenclad · Motpoly XR · NAMZARIC · NAPRELAN · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Neupro · Neuroblate · Nourianz · Nuedexta · OCREVUS · ONPATTRO · ONZETRA Xsail · OXTELLAR XR · Ocrevus · Ongentys · Ozempic · PANZYGA · PLEGRIDY · PURIFIED CORTROPHIN GEL · Ponvory · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · QUTENZA · RADICAVA · REXULTI · REYVOW · RNS Neurostimulator Kit · RYTARY · Rebif · Rystiggo · SOLIRIS · SYMPAZAN · Soliris · TECFIDERA · TROKENDI XR · TYSABRI · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VNS - Sentiva · VNS Therapy · VNS Therapy SenTiva Model 1000 Generator · VRAYLAR · VUMERITY · VYEPTI · VYVGART · XCOPRI · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Neurologists within 10 mi
7
Per 100K population
4.6
County median income
$68,750
Nearest hospital
ADVENTIST HEALTH HANFORD
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Royter is a clinical cardiology specialist, with above-average Medicare volume (top 28% in CA), with low-engagement industry engagement in the top 19% of CA peers, with 16 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Royter experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Royter performed 306 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Royter receive payments from pharmaceutical companies?
Yes. Dr. Royter received a total of $15,259 from 69 companies across 838 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Royter's costs compare to other neurologists in Hanford?
Dr. Royter's average Medicare payment per service is $72. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Royter) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Hanford
Browse neurologists in Hanford ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in CA
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in CA
Which CA neurologists receive the most from drug and device companies.
By company
Supernus Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Supernus Pharmaceuticals, Inc.
By company
Biogen, Inc. Payments to Doctors
See all physicians who received payments from Biogen, Inc.
By company
LivaNova USA, Inc. Payments to Doctors
See all physicians who received payments from LivaNova USA, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology